Cargando…

Linking a dermal permeation and an inhalation model to a simple pharmacokinetic model to study airborne exposure to di(n-butyl) phthalate

Six males clad only in shorts were exposed to high levels of airborne di(n-butyl) phthalate (DnBP) and diethyl phthalate (DEP) in chamber experiments conducted in 2014. In two 6 h sessions, the subjects were exposed only dermally while breathing clean air from a hood, and both dermally and via inhal...

Descripción completa

Detalles Bibliográficos
Autores principales: Lorber, Matthew, Weschler, Charles J, Morrison, Glenn, Bekö, Gabriel, Gong, Mengyan, Koch, Holger M, Salthammer, Tunga, Schripp, Tobias, Toftum, Jørn, Clausen, Geo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658674/
https://www.ncbi.nlm.nih.gov/pubmed/27531370
http://dx.doi.org/10.1038/jes.2016.48
_version_ 1783274054237552640
author Lorber, Matthew
Weschler, Charles J
Morrison, Glenn
Bekö, Gabriel
Gong, Mengyan
Koch, Holger M
Salthammer, Tunga
Schripp, Tobias
Toftum, Jørn
Clausen, Geo
author_facet Lorber, Matthew
Weschler, Charles J
Morrison, Glenn
Bekö, Gabriel
Gong, Mengyan
Koch, Holger M
Salthammer, Tunga
Schripp, Tobias
Toftum, Jørn
Clausen, Geo
author_sort Lorber, Matthew
collection PubMed
description Six males clad only in shorts were exposed to high levels of airborne di(n-butyl) phthalate (DnBP) and diethyl phthalate (DEP) in chamber experiments conducted in 2014. In two 6 h sessions, the subjects were exposed only dermally while breathing clean air from a hood, and both dermally and via inhalation when exposed without a hood. Full urine samples were taken before, during, and for 48 h after leaving the chamber and measured for key DnBP and DEP metabolites. The data clearly demonstrated high levels of DnBP and DEP metabolite excretions while in the chamber and during the first 24 h once leaving the chamber under both conditions. The data for DnBP were used in a modeling exercise linking dose models for inhalation and transdermal permeation with a simple pharmacokinetic model that predicted timing and mass of metabolite excretions. These models were developed and calibrated independent of these experiments. Tests included modeling of the “hood-on” (transdermal penetration only), “hood-off” (both inhalation and transdermal) scenarios, and a derived “inhalation-only” scenario. Results showed that the linked model tended to duplicate the pattern of excretion with regard to timing of peaks, decline of concentrations over time, and the ratio of DnBP metabolites. However, the transdermal model tended to overpredict penetration of DnBP such that predictions of metabolite excretions were between 1.1 and 4.5 times higher than the cumulative excretion of DnBP metabolites over the 54 h of the simulation. A similar overprediction was not seen for the “inhalation-only” simulations. Possible explanations and model refinements for these overpredictions are discussed. In a demonstration of the linked model designed to characterize general population exposures to typical airborne indoor concentrations of DnBP in the United States, it was estimated that up to one-quarter of total exposures could be due to inhalation and dermal uptake.
format Online
Article
Text
id pubmed-5658674
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-56586742017-10-30 Linking a dermal permeation and an inhalation model to a simple pharmacokinetic model to study airborne exposure to di(n-butyl) phthalate Lorber, Matthew Weschler, Charles J Morrison, Glenn Bekö, Gabriel Gong, Mengyan Koch, Holger M Salthammer, Tunga Schripp, Tobias Toftum, Jørn Clausen, Geo J Expo Sci Environ Epidemiol Original Article Six males clad only in shorts were exposed to high levels of airborne di(n-butyl) phthalate (DnBP) and diethyl phthalate (DEP) in chamber experiments conducted in 2014. In two 6 h sessions, the subjects were exposed only dermally while breathing clean air from a hood, and both dermally and via inhalation when exposed without a hood. Full urine samples were taken before, during, and for 48 h after leaving the chamber and measured for key DnBP and DEP metabolites. The data clearly demonstrated high levels of DnBP and DEP metabolite excretions while in the chamber and during the first 24 h once leaving the chamber under both conditions. The data for DnBP were used in a modeling exercise linking dose models for inhalation and transdermal permeation with a simple pharmacokinetic model that predicted timing and mass of metabolite excretions. These models were developed and calibrated independent of these experiments. Tests included modeling of the “hood-on” (transdermal penetration only), “hood-off” (both inhalation and transdermal) scenarios, and a derived “inhalation-only” scenario. Results showed that the linked model tended to duplicate the pattern of excretion with regard to timing of peaks, decline of concentrations over time, and the ratio of DnBP metabolites. However, the transdermal model tended to overpredict penetration of DnBP such that predictions of metabolite excretions were between 1.1 and 4.5 times higher than the cumulative excretion of DnBP metabolites over the 54 h of the simulation. A similar overprediction was not seen for the “inhalation-only” simulations. Possible explanations and model refinements for these overpredictions are discussed. In a demonstration of the linked model designed to characterize general population exposures to typical airborne indoor concentrations of DnBP in the United States, it was estimated that up to one-quarter of total exposures could be due to inhalation and dermal uptake. Nature Publishing Group 2017-11 2016-08-17 /pmc/articles/PMC5658674/ /pubmed/27531370 http://dx.doi.org/10.1038/jes.2016.48 Text en Copyright © 2017 Nature America, Inc., part of Springer Nature. http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Original Article
Lorber, Matthew
Weschler, Charles J
Morrison, Glenn
Bekö, Gabriel
Gong, Mengyan
Koch, Holger M
Salthammer, Tunga
Schripp, Tobias
Toftum, Jørn
Clausen, Geo
Linking a dermal permeation and an inhalation model to a simple pharmacokinetic model to study airborne exposure to di(n-butyl) phthalate
title Linking a dermal permeation and an inhalation model to a simple pharmacokinetic model to study airborne exposure to di(n-butyl) phthalate
title_full Linking a dermal permeation and an inhalation model to a simple pharmacokinetic model to study airborne exposure to di(n-butyl) phthalate
title_fullStr Linking a dermal permeation and an inhalation model to a simple pharmacokinetic model to study airborne exposure to di(n-butyl) phthalate
title_full_unstemmed Linking a dermal permeation and an inhalation model to a simple pharmacokinetic model to study airborne exposure to di(n-butyl) phthalate
title_short Linking a dermal permeation and an inhalation model to a simple pharmacokinetic model to study airborne exposure to di(n-butyl) phthalate
title_sort linking a dermal permeation and an inhalation model to a simple pharmacokinetic model to study airborne exposure to di(n-butyl) phthalate
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658674/
https://www.ncbi.nlm.nih.gov/pubmed/27531370
http://dx.doi.org/10.1038/jes.2016.48
work_keys_str_mv AT lorbermatthew linkingadermalpermeationandaninhalationmodeltoasimplepharmacokineticmodeltostudyairborneexposuretodinbutylphthalate
AT weschlercharlesj linkingadermalpermeationandaninhalationmodeltoasimplepharmacokineticmodeltostudyairborneexposuretodinbutylphthalate
AT morrisonglenn linkingadermalpermeationandaninhalationmodeltoasimplepharmacokineticmodeltostudyairborneexposuretodinbutylphthalate
AT bekogabriel linkingadermalpermeationandaninhalationmodeltoasimplepharmacokineticmodeltostudyairborneexposuretodinbutylphthalate
AT gongmengyan linkingadermalpermeationandaninhalationmodeltoasimplepharmacokineticmodeltostudyairborneexposuretodinbutylphthalate
AT kochholgerm linkingadermalpermeationandaninhalationmodeltoasimplepharmacokineticmodeltostudyairborneexposuretodinbutylphthalate
AT salthammertunga linkingadermalpermeationandaninhalationmodeltoasimplepharmacokineticmodeltostudyairborneexposuretodinbutylphthalate
AT schripptobias linkingadermalpermeationandaninhalationmodeltoasimplepharmacokineticmodeltostudyairborneexposuretodinbutylphthalate
AT toftumjørn linkingadermalpermeationandaninhalationmodeltoasimplepharmacokineticmodeltostudyairborneexposuretodinbutylphthalate
AT clausengeo linkingadermalpermeationandaninhalationmodeltoasimplepharmacokineticmodeltostudyairborneexposuretodinbutylphthalate